Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol

Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol

Antonio Molino,1,* Giovanna Calabrese,1,* Mauro Maniscalco2 1Division of Pneumology, Department of Respiratory Diseases, University of Naples Federico II, AORN dei Colli-Monaldi Hospital, Naples, Italy; 2Pulmonary Rehabilitation Division, ICS Maugeri SpA SB, Institute of Telese Terme, Telese Terme,...

Full description

Bibliographic Details
Main Authors: Molino A, Calabrese G, Maniscalco M
Format: Article
Language:English
Published: Dove Medical Press 2018-06-01
Series:Patient Preference and Adherence
Subjects:
COPD
fluticasone
triple therapy
umeclidinium
vilanterol
rehabilitation
Online Access:https://www.dovepress.com/-focus-on-the-new-combination-patient-considerations-in-the-treatment-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/-focus-on-the-new-combination-patient-considerations-in-the-treatment-peer-reviewed-article-PPA

Similar Items